Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Stem Cell Hematopoetic Transplant”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07252050
What this trial is testing

Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseHematopoetic Stem Cell TransplantHaploidentical Hematopoietic Stem Cell Transplant+2 more
University of Colorado, Denver 24
Early research (Phase 1)Study completedNCT01215734
What this trial is testing

Standard vs High-Dose Trivalent Inactivated Flu Vaccine in Adult Hematopoetic Stem Cell Transplant (HSCT) Recipients

Who this might be right for
Adult Stem Cell Hematopoetic Transplant
Vanderbilt-Ingram Cancer Center 44
Large-scale testing (Phase 3)Active Not RecruitingNCT06475820
What this trial is testing

Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With Hemoblastosis

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaBiphenotypic Acute Leukemia+2 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 150
Large-scale testing (Phase 3)Active Not RecruitingNCT05515029
What this trial is testing

Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis

Who this might be right for
Acute Lymphoblastic LeukemiaMyeloblastic LeukemiaBiphenotypic Acute Leukemia+3 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 56
Large-scale testing (Phase 3)Looking for participantsNCT06756152
What this trial is testing

Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis

Who this might be right for
Biphenotypic Acute LeukemiaAcute Lymphoblastic LeukemiaMyeloblastic Leukemia+3 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 50